Longitudinal platelet reactivity to acute psychological stress among older men and women

Stress

Volumn 12, Issue 5, 2009, Pages 426-433

  Aschbacher, Kirstin ^a   Von Känel, Roland ^a,b   Mills, Paul J ^a   Roepke, Susan K ^a   Hong, Suzi ^a   Dimsdale, Joel E ^a   Mausbach, Brent T ^a   Patterson, Thomas L ^a,c   Ziegler, Michael G ^d   Ancoli Israel, Sonia ^a,c   Grant, Igor ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Cardiovascular disease; Coagulation; GPIIb IIIa; Hemostasis; Platelet hyperreactivity; Psychological stress

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PADGEM PROTEIN;

ACUTE STRESS; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DRUG USE; EXERCISE TEST; FEMALE; FLOW CYTOMETRY; GERIATRIC PATIENT; HABITUATION; HEART INFARCTION; HORMONE SUBSTITUTION; HUMAN; LABORATORY TEST; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOLOGIC TEST; SEX DIFFERENCE; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION;

AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; ASPIRIN; BLOOD PLATELETS; FEMALE; HABITUATION, PSYCHOPHYSIOLOGIC; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION; PLATELET AGGREGATION; RECEPTORS, FIBRINOGEN; STRESS, PSYCHOLOGICAL;

EID: 70549113759     PISSN: 10253890     EISSN: 16078888     Source Type: Journal    
DOI: 10.1080/10253890802574993     Document Type: Article

References (59)

1. Aschbacher K, Patterson TL, et al. 2005. Coping processes and hemostatic reactivity to acute stress in dementia caregivers. Psychosom Med 67:964-971.
2. Aschbacher K, von Känel R, et al. 2006. Increasing dementia of the care receiver predicts procoagulant response in Alzheimer caregivers. Am J Geriat Psychiatry 14:694-703.
3. Balk EM, Lau J, et al. 2003. Effects of statin on non-lipid serum markers associated with cardiovascular disease. Arch Intern Med 139:670-682.
4. Blann AD, Nadar SK, Lip GY. 2003. The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J 24:2166-2179.
5. Brydon L, Magid K, Steptoe A. 2006. Platelets, coronary heart disease, and stress. Brain Behav Immun 20:113-119.
6. Camacho A, Dimsdale JE. 2000. Platelets and psychiatry: lessons learned from old and new studies. Psychosom Med 62:326-336.
7. Croce K, Libby P. 2007. Intertwining of thrombosis and inflammation in atherosclerosis. Curr Opin Hematol 14:55-61.
8. Dajani EZ, Shahwan TG, Dajani NE. 2002. Statins, platelet aggregation and coronary heart disease. J Assoc Acad Minor Phys 13:27-31.
9. Danesh J, Whincup P, et al. 2001. Fibrin D-dimer and coronary heart disease: Prospective study and meta-analysis. Circulation 103:2323-2327.
10. Furman MI, Barnard MR, et al. 2001. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol 38:1002-1006.
11. Hamaad A, Lip GY, MacFadyen RJ. 2003. Unheralden sudden cardiac death: Do autonomic tone and thrombosis interact as key factors in aetiology? Ann Med 35:592-604.
12. Hamer M, Gibson EL, et al. 2006. Inflammatory and hemostatic responses to repeated mental stress: Individual stability and habituation over time. Brain Behav Immun 20:456-459.
13. Harrison P. 2000. Progress in the assessment of platelet function. Br J Haematol 111:733-744.
14. Hjemdahl P, Chronos NA, et al. 1994. Epinephrine sensitizes human platelets in vivo and in vitro as studied by fibrinogen binding and P-selectin expression. Arterioscler Thromb Vasc Biol 14:77-84.
15. Hu H, Varon D, et al. 2003. Platelet-leukocyte aggregation under shear stress: Differential involvement of selectins and integrins. Thromb Haemost 90:679-687.
16. Hussein O, Rosenblat M, et al. 1997. Reduced platelet aggregation after fluvastatin therapy is associated with altered platelet lipid composition and drug binding to the platelets. Br J Clin Pharmacol 44:77-84.
17. Ishida F, Furihata K, et al. 1996. The largest isoform of platelet mebrane glycoprotein Ib alpha is commonly distributed in eastern Asian populations. Thromb Haemost 76:245-247.
18. Jayachandran M, Karnicki K, et al. 2005. Platelet characteristics change with aging: Role of estrogen receptor B. J Gerontol 60A:815-819.
19. Jorgensen L. 2006. The role of platelets in the initial stages of atherosclerosis. J Thromb Haemost 4:1443-1449.
20. Kamarck TW, Lovallo WR. 2003. Cardiovascular reactivity to psychological challenge: Conceptual and measurement considerations. Psychosom Med 65:9-21.
21. Knight CJ, Panesar M, et al. 1997. Altered platelet function detected by flow cytometry. Arterioscler Thromb Vasc Biol 17:2044-2053.
22. Kung H-C, Hoyert DL, Jiaquan X, Murphy SL. 2008. Deaths: Final data for 2005. National Vital Statistics Reports. 56. Internet Version.
23. Lederbogen F, Baranyai R, et al. 2004. Effect of mental and physical stress on platelet activation markers in depressed patients and healthy subjects: A pilot study. Psychiatry Res 127:55-64.
24. Lee KW, Lip GYH. 2003. Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity. Arch Intern Med 163:2368-2392.
25. Linden MD, Frelinger AL, et al. 2004. Application of flow cytometry to platelet disorders. Semin Thromb Hemost 30:501-511.
26. Markovitz JH, Matthews KA. 1991. Platelets and coronary heart disease: Potential psychophysiologic mechanisms. Psychosom Med 53:643-668.
27. Markovitz JH, Matthews KA, Kiss J, Smitherman TC. 1996. Effects of hostility on platelet reactivity to psychological stress in coronary heart disease patients and in healthy controls. Psychosom Med 58:143-149.
28. Mausbach BT, Aschbacher K, et al. 2007. Effects of placement and bereavement on psychological well-being and cardiovascular risk in Alzheimer's caregivers: A longitudinal analysis. J Psychosom Res 62:439-445.
29. McKenzie ME, Malinin AI, et al. 2003. Aspirin inhibits surface glycoprotein IIb/IIIa, P-selectin, CD63, and CD107a receptor expression on human platelets. Blood Coagul Fibrinolysis 14:249-253.
30. Merten M, Thiagarajan P. 2000. P-selectin expression on platelets determines size and stability of platelet aggregates. Circulation 102:1931-1936.
31. Michelson AD. 2006. Evaluation of platelet function by flow cytometry. Pathophysiol Haemost Thromb 35:67-82.
32. Michelson A, Furman M. 1999. Laboratory markers of platelet activation and their clinical significance. Curr Opin Hematol 6:342-348.
33. Mukamal KJ. 2004. Traditional and novel risk factors in older adults: Cardiovascular risk assessment late in life. Am J Geriatric Cardiol 13:69-80.
34. Musselman DL, Marzec UM, et al. 2000. Platelet reactivity in depressed patients treated with paroxetine: Preliminary findings. Arch Gen Psychiatry 57:875-882.
35. Musumeci V, Baroni S, et al. 1987. Cardiovascular reactivity, plasma markers of endothelial and platelet activity and plasma renin activity after mental stress in normals and hypertensives. J Hypertens Suppl.
36. Ogston D, McDonald GA, Fullerton HW. 1962. The influence of anxiety in tests of blood coagulability and fibrinolytic activity. Lancet 2:521-523.
37. Patterson SM, Zakowski SG, et al. 1994. Psychological stress and platelet activation: Differences in platelet reactivity in healthy men during active and passive stressors. Health Psychol 13:34-38.
38. Prescott SM, McIntyre TM, Zimmerman GA, Stafforini DM. 1996. Inflammation as an early component of atherosclerosis and vascular damage-a role for p-selectin and platelet activating factor. Jpn Circ J 60:137-141.
39. Saab PG, Llabre MM, et al. 1992. Myocardial and peripheral vascular responses to behavioral challenges and their stability in black and white Americans. Psychophysiology 29:384-397.
40. Schwartz AR, Gerin W, et al. 2003. Toward a causal model of cardiovascular responses to stress and the development of cardiovascular disease. Psychosom Med 65:22-35.
41. Sestito A, Maccallini A, et al. 2005a. Platelet reactivity in response to mental stress in syndrome X and in stable or unstable coronary artery disease. Thromb Res 116:25-31.
42. Sestito A, Sgueglia GA, Lanza GA. 2005b. Differences in platelet reactivity response to mental stress in syndrome X and coronary artery disease: A biased result only? Thromb Res: Epub.
43. Sharkey SW, Lesser JR, et al. 2005. Acute and reversible cardiomyopathy provoked by stress in women from the United States. Circulation 111:472-479.
44. Shattil SJ, Cunningham M, Hoxie JA. 1987. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 70:307-315.
45. Sherwood A, Turner JR. 1995. Hemodynamic responses during psychological stress: Implications for studying disease processes. Int J Behav Med 2:193-218.
46. Strike PC, Steptoe A. 2003. Systematic review of mental stress-induced myocardial ischaemia. Eur Heart J 24:690-703.
47. Strike PC, Magid K, et al. 2004. Exaggerated platelet and hemodynamic reactivity to mental stress in men with coronary artery disease. Psychosom Med 66:492-500.
48. Strike PC, Perkins-Porras L, et al. 2006. Triggering of acute coronary syndromes by physical exertion and anger: Clinical and sociodemographic characteristics. Heart 92:1035-1040.
49. Taylor TR, Kamarck TW, Dianzumba S. 2003. Cardiovascular reactivity and left ventricular mass: An integrative review. Ann Behav Med 26:182-193.
50. Thrall G, Lane D, Lip GYH. 2006. Differences in the platelet reactivity response to mental stress in cardiac syndrome X patients compared to known coronary artery disease patients: Concepts, explanations and methodological weaknesses. Thromb Res 117:351-352.
51. Treiber FA, Kamarck TW, et al. 2003. Cardiovascular reactivity and development of preclinical and clinical disease states. Psychsom Med 65:46-62.
52. Vericel E, Croset M, et al. 1988. Platelets and aging. I-aggregation, arachidonate metabolism and antioxidant status. Thromb Res 49:331-342.
53. Vokonas PS, Kannel WB, Cupples LA. 1988. Epidemiology and risk of hypertension in the elderly: The Framingham Study. J Hypertens 6:S3-S9.
54. von Känel R, Mills PJ, Fainman C, Dimsdale JE. 2001. Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: A biobehavioral pathway to coronary artery disease? Psychosom Med 63:531-544.
55. von Känel R. 2004. Platelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: How strong is the evidence? Acta Psychiatr Scand 110:163-177.
56. von Känel R, Preckel D, et al. 2004. The effect of natural habituation on coagulation responses to acute mental stress and recovery in men. Thromb Haemost 92:1327-1335.
57. Wallen NH, Held C, Rehnqvist N, Hjemdahl P. 1997. Effects of mental and physical stress on platelet function in patietns with stable agina pectoris and healthy controls. Eur Heart J 18:807-815.
58. William MS, Ng'alla LS, Vaidya D. 2007. Platelet functional implications of glycoprotein Ibalpha polymorphisms in African Americans. Am J Hematol 82:15-22.
59. Yip J, Shen Y, Berndt MC, Andrews RK. 2005. Primary platelet adhesion receptors. Int Union Biochem Mol Biol Life 57:103-108